Bio-Rad Laboratories Inc (BIO)
275.60
-2.61
(-0.94%)
USD |
NYSE |
Apr 25, 16:00
275.62
+0.02
(+0.01%)
After-Hours: 20:00
Bio-Rad Laboratories Net Income (TTM): -637.32M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -637.32M |
| September 30, 2023 | -159.30M |
| June 30, 2023 | -428.36M |
| March 31, 2023 | -191.23M |
| December 31, 2022 | -3.628B |
| September 30, 2022 | -6.021B |
| June 30, 2022 | -1.930B |
| March 31, 2022 | -90.50M |
| December 31, 2021 | 4.254B |
| September 30, 2021 | 6.667B |
| June 30, 2021 | 4.053B |
| March 31, 2021 | 4.106B |
| December 31, 2020 | 3.814B |
| September 30, 2020 | 3.521B |
| June 30, 2020 | 1.947B |
| March 31, 2020 | 1.579B |
| December 31, 2019 | 1.759B |
| September 30, 2019 | 376.66M |
| June 30, 2019 | 904.80M |
| March 31, 2019 | 574.04M |
| December 31, 2018 | 365.61M |
| September 30, 2018 | 1.277B |
| June 30, 2018 | 1.030B |
| March 31, 2018 | 766.61M |
| December 31, 2017 | 122.25M |
| Date | Value |
|---|---|
| September 30, 2017 | 16.82M |
| June 30, 2017 | 13.16M |
| March 31, 2017 | 26.14M |
| December 31, 2016 | 26.00M |
| September 30, 2016 | 94.32M |
| June 30, 2016 | 93.29M |
| March 31, 2016 | 103.70M |
| December 31, 2015 | 109.24M |
| September 30, 2015 | 102.65M |
| June 30, 2015 | 96.79M |
| March 31, 2015 | 100.00M |
| December 31, 2014 | 88.84M |
| September 30, 2014 | 79.94M |
| June 30, 2014 | 61.34M |
| March 31, 2014 | 64.31M |
| December 31, 2013 | 77.79M |
| September 30, 2013 | 90.91M |
| June 30, 2013 | 140.64M |
| March 31, 2013 | 154.38M |
| December 31, 2012 | 165.23M |
| September 30, 2012 | 182.01M |
| June 30, 2012 | 185.27M |
| March 31, 2012 | 176.98M |
| December 31, 2011 | 179.01M |
| September 30, 2011 | 186.89M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-6.021B
Minimum
Sep 2022
6.667B
Maximum
Sep 2021
1.047B
Average
904.80M
Median
Jun 2019
Net Income (TTM) Benchmarks
| Agilent Technologies Inc | 1.236B |
| Bruker Corp | 427.20M |
| Azenta Inc | -18.75M |
| Harvard Bioscience Inc | -3.415M |
| Bionano Genomics Inc | -232.49M |